The largest database of trusted experimental protocols

12 protocols using transferrin

1

Plasma Biomarkers Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma IL-6 (Invitrogen, Vienna, Austria), transferrin (Abcam, Cambridge, UK), ferritin (Abcam, Cambridge, UK) and G-CSF (MyBioSource, San Diego, CA) were measured by sandwich enzyme linked immunosorbent assay. All samples were run in duplicate following the manufacturer’s protocol.
+ Open protocol
+ Expand
2

Cytokine and Iron Biomarker Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Supernatants were centrifugated 10 min, 13,000×g, 4 °C. ELISAs were performed according to manufacturer’s instruction: human Hepcidin (R&D Systems, cat#DY8307-05), IL-6 (R&D Systems, cat#DY602), TNFα (R&D Systems, cat#DY2010), IL-8 (R&D Systems, cat#DY208), lactoferrin (abcam, cat#ab108882), and transferrin (abcam, cat#ab108902).
+ Open protocol
+ Expand
3

Biomarker Validation in Lymphoma Subtypes

Check if the same lab product or an alternative is used in the 5 most similar protocols
We validated the proteins detected and their associated biological pathways by literature review, and selected three CSF proteins (haemopexin, apolipoprotein A1 and transferrin) as candidate biomarkers. Eighteen tissue samples used for analyses included six cases with nodal diffuse large B cell lymphoma (NDLBCL), six cases with primary CNS DLBCL, and six cases with normal lymph nodes.
Immunohistochemical staining involved a standard technique with the avidin-biotinylated peroxidase complex method. Apolipoprotein A1 antibody was diluted at 1:100 (Abcam, USA). Haemopexin and transferrin antibody were diluted at 1:200 (Abcam, USA). For each biomarker, images were scored visually by two pathologists, with more than 10% stained cells defined as positive. The degree of reactivity with each section was scored as the product of the scores for the intensity and extent of staining. The intensity of immunoreactivity was graded 0-3+ for no staining, weak, medium, and strong staining, respectively.
+ Open protocol
+ Expand
4

Antibody Panel for OXPHOS and Adipogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transferrin (ab82411; rabbit polyclonal) and the MitoProfile Total OXPHOS Rodent WB antibody mixture (ab110413; rabbit polyclonal) antibodies were purchased from Abcam (Cambridge, MA). Anti-PPARγ (E-8; sc-7273; mouse monoclonal) antibody was purchased from Santa Cruz Biotechnology (Dallas, TX). Anti-adiponectin (PA1-054; rabbit polyclonal) antibody was purchased from Thermo Scientific (Waltham, MA). Anti-DBC1 (5693S; rabbit polyclonal), anti-FASN (3180S; C20G5; rabbit monoclonal), anti-ERK1/2 (4695S; 137F5; rabbit monoclonal), and anti-MYST1 (4682S; D5T3R; rabbit monoclonal) antibodies were purchased from Cell Signaling Technology (Danvers, MA).
+ Open protocol
+ Expand
5

Ferroptosis Regulation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
β-elemene (>98%) (#E4418) was purchased from LKT. Stock solution at 100 mg/ml was made in ethanol and stored at -4°C. Cetuximab (#33657) was purchased from MCE. Antibodies against GPX4 (#GR251529-34), HO-1 (#GR3187585-3), Glutaminase (#GR3299063-1), SLC40A1 (#GR215168-39), Transferrin (#GR3207592-9), SLC7A11 (#GR3235736-6) were purchased from Abcam. N-Cadherin (#13116S), E-Cadherin (#14472S), MMP9 (#13667S), snail (#3879T), slug (#9585T), and GAPDH (#2118S) antibodies were obtained from Cell Signaling Technology. Vimentin (#SA10106DB) was purchased from ABGENT. Ki67 (#66434-1-Ig) was purchased from Proteintech. Deferoxamine (#CS-4479), Ferrostain-1 (#HY-100579), Necrostain-1 (#HY-15760) were purchased from MCE. Z-VAD-FMK (#V116) was obtained from Sigma Aldrich. Liproxstatin-1 (#S7699) and RSL3 (#S8155) were purchased from Selleck Chemical.
+ Open protocol
+ Expand
6

Urinary Biomarkers for Acute Kidney Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELISA kits were used to measure urinary levels of KIM-1 (Cusabio, Wuhan, China), NGAL (Bioporto, Hellerup, Denmark), albumin (Abcam), transferrin (Abcam, Cambridge, UK), TIMP-2 (Abcam) and IGFBP-7 (Cloud Clone, Houston TX, USA), following the manufacturer instructions. The product of [TIMP-2]*[IGFBP7] urinary concentrations is marketed as NephroCheck®, and improves the diagnostic accuracy and outcomes of AKI patients. We have chosen these biomarkers due to previous studies by our research group21 (link) and others36 (link),40 (link) which show their increased urinary levels in AKI patients and in different experimental models of AKI.
+ Open protocol
+ Expand
7

Quantifying Thyroid Hormone Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total T3 (tT3) and T4 (tT4) levels as well as transferrin concentrations in serum were analyzed applying an enzyme-linked immunosorbent assay kit (tT3 and tT4: Abnova Corporation, Taipei City, Taiwan; transferrin: Abcam, Cambridge, UK). To this end, serum samples were either applied undiluted (tT3), after a 1:2 (tT4) or 1:200,000 dilution (transferrin) to the microplate, following manufacturer’s instructions. The average absorbance was measured at 450 nm using a microplate reader (Synergy H1, BioTek, Bad Friedrichshall, Germany). Calculation of concentrations was performed based on standard curves.
TSH levels in serum were measured by using the Mouse Pituitary Magnetic Bead Panel-Endocrine Multiplex Assay (MPTMAG-49K, Millipore, Darmstadt, Germany) and a Luminex 200 device, based on the Luminex xMAP technology. Assay was performed in accordance with the manual. Average CV [%] of all included samples was <10%.
+ Open protocol
+ Expand
8

Cerebral Cortex Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteins were extracted from the cerebral cortices (bregma +2 to −3 mm) and the plasma 24 h after stroke. The two assays were conducted as described.23 (link),27 (link) The following primary antibodies were used for Western blotting: MMP-3 (1:1000; Abcam); β-actin (1:1000; Sigma); transferrin (1:1000; Abcam). Semiquantitative assessment of immunoblots and MMP bands was performed by computerized densitometry.
+ Open protocol
+ Expand
9

Caveolin-1 Dynamics in TNBC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells from both TNBC cell lines were pre-incubated in serum-free media and treated with 0.5 mM MβCD for 48 hours. Treated cells were subjected to 1% Triton X-100 followed by OptiPrep gradient separation to isolate detergent resistant membrane (DRM) and non-DRM fractions. A specific enzyme linked immunosorbent assay (ELISA) kit was used to analyze caveolin-1 (MyBioSource, San Diego, USA) and transferrin levels (Abcam, Cambridge, USA).
+ Open protocol
+ Expand
10

Plasma Biomarkers in Alzheimer's Disease

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma from AD patients and non-demented (ND) controls was obtained from the University of Kentucky Sanders-Brown Center on Aging (Group 1) and Washington University Knight Alzheimer’s Disease Research Center (Group 2). Group 1 AD cases were defined by clinical diagnosis of AD as well as postmortem Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) neuritic plaque score [44 (link)] of B or C, corresponding to probable or definite AD, respectively. ND cases had CERAD score 0 and no clinical diagnosis of AD (Supplemental Table 1). Group 2 AD cases had a Clinical Dementia Rating score (CDR; measuring cognitive function) [45 (link)] of ≥0.5 and CSF Aβ42 levels <500 pg/ml, and ND cases had a CDR score of 0 and CSF Aβ42 levels >500 pg/ml (Supplemental Table 2). For Group 1, blood was drawn into heparinized plastic Vacutainer tubes. For Group 2, blood was drawn using EDTA-coated syringes into polypropylene tubes containing a final concentration of 5 mM EDTA.
Equal amounts of total protein from each sample (as determined by BCA) were analyzed by Western blot with antibodies against FXI (HTI), C1 esterase inhibitor (Proteintech), fibrin beta chain (59D8 [46 (link)]), D-dimer (AbD Serotec) and transferrin (Abcam). Purified FXI, C1 esterase inhibitor (Athens Research and Technology), and FXI-deficient plasma (George King Biomedical) served as controls.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!